Skip to content

Ultraspound-guided Intralesional Injection of Cystic Hygroma - A Case Report

Ultrasound-guided Intralesional Injection of Cystic Hygroma - A Case Report

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07246928
Acronym
US: Ultrasound
Enrollment
1
Registered
2025-11-24
Start date
2024-09-01
Completion date
2025-10-06
Last updated
2026-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Hygroma (Macro-cystic Lymphatic Malformation), Intralesional Injection of Cystic Hygroma

Brief summary

Ultrasound-guided Intralesional Injection of Cystic Hygroma - A Case Report

Detailed description

Ultrasound-guided Intralesional Injection of Cystic Hygroma \[lymphatic malformation\]

Interventions

Aspiration of Cystic Hygroma Fluid and Intralesional Injection

Sponsors

Delta University for Science and Technology
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Case Report

Eligibility

Sex/Gender
ALL
Age
1 Months to 12 Years
Healthy volunteers
No

Inclusion criteria

Pediatric patients of age up to 12 years having cystic hygromas (macrocystic lymphatic malformations), from the vascular anomalies clinic at the pediatric surgery department in Cairo University Specialized Pediatric Hospital (Abu EL-Reesh hospital). -

Design outcomes

Primary

MeasureTime frameDescription
improvement: change in lesion sizeone yearreduction in lesion size
improvement: reduction of lesion sizeone year

Countries

Egypt

Contacts

STUDY_DIRECTORGamal El-Tagy, MD

pediatric surgery department, Cairo University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 1, 2026